| Literature DB >> 29983751 |
Carlos Gustavo M G Lima1, Laercio Joel Franco2, Amaury L Dal Fabbro2, Edson Z Martinez2, João Paulo Botelho Veira-Filho3, Alexandre A C M Ventura4, Leonardo Prevelato1, Antonio Augusto V Cruz1.
Abstract
BACKGROUND: To describe the frequency of diabetic retinopathy (DR) and its associated variables in Brazilian Xavante Indians.Entities:
Keywords: Diabetes mellitus; Diabetic retinopathy; Indians; South American
Year: 2018 PMID: 29983751 PMCID: PMC6001219 DOI: 10.1186/s13098-018-0348-z
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Diabetic retinopathy in Xavante Indians according to clinical and laboratory data
| Variable | Diabetic retinopathy | ||
|---|---|---|---|
| Yes (n = 27) | No (n = 113) | ||
| Mean (min–max) | Mean (min–max) | ||
| Diabetes duration (months) | 77.1 (12–180) | 28.7 (0–132) | < 0.01 |
| Fasting glucose (mg/dL) | 356.4 (230–600) | 219.7 (72–600) | < 0.01b |
| Total cholesterol (mg/dL) | 162.5 (124–280) | 148.4 (15–378) | 0.06b |
| Triglycerides (mg/dL) | 309.9 (88–3654) | 220.3 (53–1981) | 0.02b |
| HDL cholesterol (mg/dL) | 40.0 (26.0–63.0) | 39.3 (23.6–59.0) | 0.63b |
| LDL cholesterol (mg/dL) | 75.4 (10–140) | 69.2 (27–116) | 0.32 |
| C-reactive protein (mg/L) | 2.92 (0.48–41.44) | 3.78 (0.35–83.05) | 0.28b |
| HbA1c (%) | 12.5 (8.2–16.0) | 9.76 (5.5–18.8) | < 0.01b |
| Microalbuminuria (mg/L) | 49.8 (2.2–778) | 17.2 (1.1–5190) | < 0.01b |
| Apolipoprotein A–I (mg/dL) | 114.1 (96.8–143) | 110.7 (73–229.2) | 0.23b |
| Apolipoprotein B (mg/dL) | 71.4 (30.4–113) | 75.2 (38–134) | 0.42b |
aStudent’s t test for mean comparison
bData were transformed in logarithmic values to a skewed distribution. In these cases, data are described by geometric means
Frequency of diabetic retinopathy in Brazilian Xavante Indians according to clinical data and age and sex adjusted prevalence ratios
| Total | Diabetic Retinopathy | Crude PR (95% CI) | Adjusted PR (95% CI) | ||
|---|---|---|---|---|---|
|
| % | ||||
| Age (years) | |||||
| 18–39 | 44 | 2 | 4.6 | Reference | Reference |
| 40–59 | 59 | 16 | 27.1 | 6.0 (1.4–24.6)* | 6.3 (1.5–26.2)* |
| 60 or more | 37 | 9 | 24.3 | 5.3 (1.2–23.2)* | 5.4 (1.2–23.5)* |
| Sex | |||||
| Men | 40 | 7 | 17.5 | Reference | Reference |
| Women | 100 | 20 | 20.0 | 1.1 (0.5–2.5) | 1.4 (0.6–3.0) |
| Duration of DM | |||||
| ≤ 24 months | 73 | 2 | 2.7 | Reference | Reference |
| 25–108 months | 57 | 17 | 29.8 | 10.9 (2.6–45.2)* | 2.3 (1.4–3.7)* |
| > 108 months | 10 | 8 | 80.0 | 29.2 (7.2–118.6)* | 3.8 (2.0–7.0)* |
| Smoking | |||||
| Yes | 15 | 1 | 6.7 | Reference | Reference |
| No | 125 | 26 | 20.8 | 3.1 (0.4–21.4) | 2.6 (0.3–17.7) |
| Waist circumference | |||||
| Abnormal | 104 | 17 | 16.4 | Reference | Reference |
| Normal | 36 | 10 | 27.8 | 1.7 (0.8–3.4) | 3.1 (1.3–7.4)* |
| BMI (kg/m2) | |||||
| < 25 | 19 | 6 | 31.6 | Reference | Reference |
| 25–29.9 | 51 | 13 | 25.5 | 0.8 (0.3–1.8) | 0.5 (0.2–1.4) |
| ≥ 30 | 70 | 8 | 11.4 | 0.4 (0.1–0.9)* | 0.3 (0.1–0.8)* |
| Hypertension | |||||
| No | 116 | 24 | 20.7 | Reference | Reference |
| Yes | 24 | 3 | 12.5 | 0.6 (0.1–1.8) | 0.5 (0.1–1.5) |
| Cataract | |||||
| No | 103 | 16 | 15.5 | Reference | Reference |
| Yes | 37 | 11 | 29.7 | 1.9 (0.9–3.7) | 1.8 (0.8–4.1) |
| Papillary excavation | |||||
| 0.1–0.4 | 128 | 21 | 16.4 | Reference | Reference |
| 0.5–0.9 | 12 | 6 | 50.0 | 3.0 (1.5–6.1) | 2.7 (1.3–5.4)* |
| Visual acuity | |||||
| 0–0.5 | 117 | 21 | 18.0 | Reference | Reference |
| 0.6–0.9 | 17 | 4 | 23.5 | 1.3 (0.5–3.4) | 1.0 (0.3–2.7) |
| ≥ 1 | 5 | 2 | 40.0 | 2.2 (0.7–7.0) | 1.8 (0.6–5.3) |
| Fasting glycemia | |||||
| < 140 mg/dL | 35 | 0 | 0 | Reference | |
| 140 mg/dL | 105 | 27 | 25.7 | ||
| Total cholesterol | |||||
| < 200 mg/dL | 121 | 25 | 20.7 | Reference | Reference |
| ≥ 200 mg/dL | 15 | 2 | 13.3 | 0.6 (0.1–2.5) | 0.7 (0.2–2.8) |
| HDL | |||||
| Normal | 24 | 5 | 20.8 | Reference | Reference |
| Abnormal | 112 | 22 | 19.6 | 0.9 (0.3–2.2) | 0.7 (0.2–1.7) |
| Triglycerides | |||||
| < 150 mg/dL | 32 | 2 | 6.2 | Reference | Reference |
| ≥ 150 mg/dL | 104 | 25 | 24.0 | 3.9 (0.9–15.3) | 3.7 (0.9–14.7) |
| LDL | |||||
| < 100 mg/dL | 101 | 18 | 17.8 | Reference | Reference |
| ≥ 100 mg/dL | 14 | 2 | 14.3 | 0.8 (0.2–3.1) | 0.8 (0.2–3.2) |
| C-reactive protein | |||||
| Normal | 61 | 14 | 23.0 | Reference | Reference |
| Abnormal | 75 | 13 | 17.3 | 0.7 (0.3–1.5) | 0.7 (0.3–1.4) |
| HbA1c (%) | |||||
| < 6.5 | 20 | 0 | 0 | Reference | |
| ≥ 6.5% | 104 | 27 | 26.0 | ||
| Microalbuminuria | |||||
| Normal | 76 | 13 | 17.1 | Reference | Reference |
| Abnormal | 45 | 14 | 31.1 | 1.8 (0.9–3.5) | 1.9 (1.0–3.5) |
*Significant at p < 0.05
Association between waist circumference and DR stratified by sex
| Sex | Waist circumference | Total | Diabetic Retinopathy | PR (95% CI) | |
|---|---|---|---|---|---|
|
| % | ||||
| Men | Abnormal | 16 | 2 | 12.5 | Reference |
| Normal | 24 | 5 | 20.8 | 1.7 (0.3–7.6) | |
| Women | Abnormal | 88 | 15 | 17.1 | Reference |
| Normal | 12 | 5 | 41.7 | 2.4 (1.1–5.5)* | |
*Significant at p < 0.05
Fig. 1Conditional inference tree for the RD data. The rectangles at the bottom of the figure correspond to the “terminal nodes” and visually show the probabilities of DR for each path through the tree. The first node of the conditional inference tree (the “root node”) split the data according to the duration of DM (p < 0.001). Individuals with less than 24 months of DM were classified according to the MA values (interior node 2, p < 0.001), and those with values lower than 73.3 mg/L where classified as low risk for DR (terminal node 3). On the other hand, individuals with more than 24 months of DM were classified according to the papillary excavation (interior node 5, p = 0.016), where those with papillary excavation higher than 0.2 where classified as high risk for DR (terminal node 7). It is important to note that a cut-off value of 0.2 for the papillary excavation seems to be uninterpretable in a clinical point of view and it was obtained from an algorithm merely mathematical
Association pattern between duration of DM, MA, papillary excavation and DR
| Duration of DM | Total | Diabetic retinopathy | |
|---|---|---|---|
|
| % | ||
| ≤ 24 months | |||
| Microalbuminuria normal | 40 | 0 | 0 |
| Microalbuminuria abnormal | 17 | 2 | 11.8 |
| > 24 months | |||
| Papillary excavation 0.1–0.4 | 60 | 20 | 33.3 |
| Papillary excavation 0.5–0.9 | 7 | 5 | 71.4 |